Clearpoint Neuro Stock Buy Hold or Sell Recommendation
| CLPT Stock | USD 5.32 0.18 3.27% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Clearpoint Neuro is 'Sell'. Macroaxis provides Clearpoint Neuro buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding CLPT positions. The advice algorithm takes into account all of Clearpoint Neuro's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Clearpoint Neuro's buy or sell advice are summarized below:
Real Value 7.61 | Target Price 14.5 | Hype Value 5.29 | Market Value 5.32 | Naive Value 5.13 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Clearpoint Neuro given historical horizon and risk tolerance towards Clearpoint Neuro. When Macroaxis issues a 'buy' or 'sell' recommendation for Clearpoint Neuro, the advice is generated through an automated system that utilizes algorithms and statistical models.
Clearpoint |
Execute Clearpoint Neuro Buy or Sell Advice
The Clearpoint recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Clearpoint Neuro. Macroaxis does not own or have any residual interests in Clearpoint Neuro or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Clearpoint Neuro's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Sell
Market Performance | Very Weak | Details | |
Volatility | Slightly risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Clearpoint Neuro Trading Alerts and Improvement Suggestions
| Clearpoint Neuro generated a negative expected return over the last 90 days | |
| Clearpoint Neuro has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 23.95 M. Net Loss for the year was (22.09 M) with profit before overhead, payroll, taxes, and interest of 13.53 M. | |
| Clearpoint Neuro currently holds about 45.14 M in cash with (13.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.84. | |
| Clearpoint Neuro has a poor financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: ClearPoint Neuro to Announce First Quarter 2024 Results May 7, 2024 |
Clearpoint Neuro Returns Distribution Density
The distribution of Clearpoint Neuro's historical returns is an attempt to chart the uncertainty of Clearpoint Neuro's future price movements. The chart of the probability distribution of Clearpoint Neuro daily returns describes the distribution of returns around its average expected value. We use Clearpoint Neuro price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Clearpoint Neuro returns is essential to provide solid investment advice for Clearpoint Neuro.
| Mean Return | -0.37 | Value At Risk | -6.29 | Potential Upside | 4.54 | Standard Deviation | 4.46 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Clearpoint Neuro historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Clearpoint Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Clearpoint Neuro is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Clearpoint Neuro backward and forwards among themselves. Clearpoint Neuro's institutional investor refers to the entity that pools money to purchase Clearpoint Neuro's securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Parsons Capital Management Inc | 2023-12-31 | 106.2 K | Goldman Sachs Group Inc | 2023-12-31 | 93.1 K | Citadel Advisors Llc | 2023-09-30 | 86.2 K | Bridgeway Capital Management, Llc | 2023-12-31 | 67 K | Charles Schwab Investment Management Inc | 2023-12-31 | 62.8 K | Bank Of New York Mellon Corp | 2023-12-31 | 62 K | Commonwealth Equity Services Inc | 2023-12-31 | 59.2 K | Ubs Group Ag | 2023-12-31 | 53.5 K | Royce & Associates, Lp | 2023-12-31 | 53.1 K | Blackrock Inc | 2023-12-31 | 1.5 M | Vanguard Group Inc | 2023-12-31 | 1.3 M |
Clearpoint Neuro Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (1.0M) | (25K) | (1.7M) | (4.4M) | 1.2M | 1.3M | |
| Change In Cash | 2.6M | 14.4M | 34.0M | (26.5M) | (4.5M) | (4.3M) | |
| Free Cash Flow | (3.0M) | (8.3M) | (12.9M) | (17.3M) | (14.8M) | (14.0M) | |
| Depreciation | 250.6K | 553K | 692K | 777K | 1.5M | 1.5M | |
| Other Non Cash Items | 729.3K | 893K | 425K | (346K) | (18K) | (17.1K) | |
| Capital Expenditures | 160.2K | 482K | 168K | 1.1M | 1.1M | 1.1M | |
| Net Income | (5.5M) | (6.8M) | (14.4M) | (16.4M) | (22.1M) | (21.0M) | |
| End Period Cash Flow | 5.7M | 20.1M | 54.1M | 27.6M | 23.1M | 13.2M | |
| Investments | (160.2K) | (482K) | (168K) | (9.6M) | 20.9M | 21.9M | |
| Change To Netincome | 799K | 197K | 2.6M | 4.0M | 4.6M | 4.8M |
Clearpoint Neuro Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Clearpoint Neuro or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Clearpoint Neuro's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Clearpoint stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.63 | |
β | Beta against NYSE Composite | 2.95 | |
σ | Overall volatility | 4.51 | |
Ir | Information ratio | -0.1 |
Clearpoint Neuro Volatility Alert
Clearpoint Neuro exhibits very low volatility with skewness of 0.3 and kurtosis of 6.64. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Clearpoint Neuro's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Clearpoint Neuro's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Clearpoint Neuro Fundamentals Vs Peers
Comparing Clearpoint Neuro's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Clearpoint Neuro's direct or indirect competition across all of the common fundamentals between Clearpoint Neuro and the related equities. This way, we can detect undervalued stocks with similar characteristics as Clearpoint Neuro or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Clearpoint Neuro's fundamental indicators could also be used in its relative valuation, which is a method of valuing Clearpoint Neuro by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Clearpoint Neuro to competition |
| Fundamentals | Clearpoint Neuro | Peer Average |
| Return On Equity | -0.76 | -0.31 |
| Return On Asset | -0.29 | -0.14 |
| Profit Margin | (0.92) % | (1.27) % |
| Operating Margin | (0.69) % | (5.51) % |
| Current Valuation | 139.17 M | 16.62 B |
| Shares Outstanding | 27.07 M | 571.82 M |
| Shares Owned By Insiders | 7.60 % | 10.09 % |
| Shares Owned By Institutions | 29.91 % | 39.21 % |
| Number Of Shares Shorted | 1.28 M | 4.71 M |
| Price To Earning | (3.36) X | 28.72 X |
| Price To Book | 7.44 X | 9.51 X |
| Price To Sales | 6.57 X | 11.42 X |
| Revenue | 23.95 M | 9.43 B |
| Gross Profit | 13.53 M | 27.38 B |
| EBITDA | (20.99 M) | 3.9 B |
| Net Income | (22.09 M) | 570.98 M |
| Cash And Equivalents | 45.14 M | 2.7 B |
| Cash Per Share | 1.84 X | 5.01 X |
| Total Debt | 13.94 M | 5.32 B |
| Debt To Equity | 0.28 % | 48.70 % |
| Current Ratio | 10.33 X | 2.16 X |
| Book Value Per Share | 0.86 X | 1.93 K |
| Cash Flow From Operations | (13.72 M) | 971.22 M |
| Short Ratio | 5.08 X | 4.00 X |
| Earnings Per Share | (0.90) X | 3.12 X |
| Price To Earnings To Growth | (0.46) X | 4.89 X |
| Target Price | 10.0 | |
| Number Of Employees | 107 | 18.84 K |
| Beta | 0.92 | -0.15 |
| Market Capitalization | 148.88 M | 19.03 B |
| Total Asset | 42.66 M | 29.47 B |
| Retained Earnings | (172.46 M) | 9.33 B |
| Working Capital | 28.74 M | 1.48 B |
Note: Disposition of 1730 shares by Stigall L. Jeremy of Clearpoint Neuro at 6.53 subject to Rule 16b-3 [view details]
Clearpoint Neuro Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Clearpoint . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Clearpoint Neuro Buy or Sell Advice
When is the right time to buy or sell Clearpoint Neuro? Buying financial instruments such as Clearpoint Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 12.3M | 12.0M | 13.9M | 9.8M | Total Assets | 65.6M | 55.5M | 42.7M | 23.2M |
Use Investing Ideas to Build Portfolios
In addition to having Clearpoint Neuro in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Diversified Assets Thematic Idea Now
Diversified Assets
Pablicly traded close-end funds and other entities backed by different types of diversified investments. The Diversified Assets theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Diversified Assets Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Clearpoint Neuro Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Clearpoint Stock please use our How to Invest in Clearpoint Neuro guide.You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Complementary Tools for Clearpoint Stock analysis
When running Clearpoint Neuro's price analysis, check to measure Clearpoint Neuro's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearpoint Neuro is operating at the current time. Most of Clearpoint Neuro's value examination focuses on studying past and present price action to predict the probability of Clearpoint Neuro's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearpoint Neuro's price. Additionally, you may evaluate how the addition of Clearpoint Neuro to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |
Is Clearpoint Neuro's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clearpoint Neuro. If investors know Clearpoint will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clearpoint Neuro listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.90) | Revenue Per Share 0.974 | Quarterly Revenue Growth 0.316 | Return On Assets (0.29) | Return On Equity (0.76) |
The market value of Clearpoint Neuro is measured differently than its book value, which is the value of Clearpoint that is recorded on the company's balance sheet. Investors also form their own opinion of Clearpoint Neuro's value that differs from its market value or its book value, called intrinsic value, which is Clearpoint Neuro's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clearpoint Neuro's market value can be influenced by many factors that don't directly affect Clearpoint Neuro's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Clearpoint Neuro's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clearpoint Neuro is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clearpoint Neuro's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.